These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2984980)

  • 61. A view from the Common Cold Unit.
    Tyrrell DA
    Antiviral Res; 1992 Jun; 18(2):105-25. PubMed ID: 1329647
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oxysterol-binding protein family I is the target of minor enviroxime-like compounds.
    Arita M; Kojima H; Nagano T; Okabe T; Wakita T; Shimizu H
    J Virol; 2013 Apr; 87(8):4252-60. PubMed ID: 23365445
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Echinacea in the prevention of induced rhinovirus colds: a meta-analysis.
    Schoop R; Klein P; Suter A; Johnston SL
    Clin Ther; 2006 Feb; 28(2):174-83. PubMed ID: 16678640
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rhinovirus infections in Tecumseh, Michigan: frequency of illness and number of serotypes.
    Monto AS; Bryan ER; Ohmit S
    J Infect Dis; 1987 Jul; 156(1):43-9. PubMed ID: 3036962
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections.
    Mukherjee PK; Esper F; Buchheit K; Arters K; Adkins I; Ghannoum MA; Salata RA
    BMC Infect Dis; 2017 Jan; 17(1):74. PubMed ID: 28088167
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intranasally and orally administered antihistamine treatment of experimental rhinovirus colds.
    Gaffey MJ; Gwaltney JM; Sastre A; Dressler WE; Sorrentino JV; Hayden FG
    Am Rev Respir Dis; 1987 Sep; 136(3):556-60. PubMed ID: 3307567
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A review on recent development of common cold therapeutic agents.
    Mediratta PK; Sharma KK; Verma V
    Indian J Med Sci; 2000 Nov; 54(11):485-90. PubMed ID: 11354808
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Detection of rhinovirus RNA in nasal epithelial cells by in situ hybridization.
    Bruce C; Chadwick P; al-Nakib W
    J Virol Methods; 1990 Oct; 30(1):115-25. PubMed ID: 1964938
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anti-interferon antibody increases rhinovirus isolation rates from nasal wash specimens containing interferon-alpha 2.
    Hayden FG; Gwaltney JM
    Antiviral Res; 1983 Mar; 3(1):67-71. PubMed ID: 6307140
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of the efficacy of ascorbic acid in prophylaxis of induced rhinovirus 44 infection in man.
    Schwartz AR; Togo Y; Hornick RB; Tominaga S; Gleckman RA
    J Infect Dis; 1973 Oct; 128(4):500-5. PubMed ID: 4355208
    [No Abstract]   [Full Text] [Related]  

  • 71. Transmission and control of rhinovirus colds.
    Jennings LC; Dick EC
    Eur J Epidemiol; 1987 Dec; 3(4):327-35. PubMed ID: 2446913
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Shedding of infected ciliated epithelial cells in rhinovirus colds.
    Turner RB; Hendley JO; Gwaltney JM
    J Infect Dis; 1982 Jun; 145(6):849-53. PubMed ID: 6282984
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Two randomized controlled trials of virucidal nasal tissues in the prevention of natural upper respiratory infections.
    Farr BM; Hendley JO; Kaiser DL; Gwaltney JM
    Am J Epidemiol; 1988 Nov; 128(5):1162-72. PubMed ID: 3055950
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cultivation of "difficult" viruses from patients with common colds.
    Tyrrell DA; Bynoe ML; Hoorn B
    Br Med J; 1968 Mar; 1(5592):606-10. PubMed ID: 4295363
    [No Abstract]   [Full Text] [Related]  

  • 75. Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses.
    Pevear DC; Hayden FG; Demenczuk TM; Barone LR; McKinlay MA; Collett MS
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4492-9. PubMed ID: 16251287
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Failure of human fibroblast interferon to protect against rhinovirus infection.
    Scott GM; Reed S; Cartwright T; Tyrrell D
    Arch Virol; 1980; 65(2):135-9. PubMed ID: 6158933
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Therapeutic effects of an anticholinergic-sympathomimetic combination in induced rhinovirus colds.
    Doyle WJ; Riker DK; McBride TP; Hayden FG; Hendley JO; Swarts JD; Gwaltney JM
    Ann Otol Rhinol Laryngol; 1993 Jul; 102(7):521-7. PubMed ID: 8392820
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bauhaus biology: biotechnology and the common cold.
    Edgington SM
    Biotechnology (N Y); 1992 May; 10(5):502-7. PubMed ID: 1369478
    [No Abstract]   [Full Text] [Related]  

  • 79. Antiviral therapy for enteroviruses and rhinoviruses.
    Rotbart HA
    Antivir Chem Chemother; 2000 Jul; 11(4):261-71. PubMed ID: 10950388
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sequence determinants of 3A-mediated resistance to enviroxime in rhinoviruses and enteroviruses.
    Heinz BA; Vance LM
    J Virol; 1996 Jul; 70(7):4854-7. PubMed ID: 8676522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.